U.S. Department of Health and Human Services

Cystic Fibrosis Research and Translation Centers

The NIDDK-supported Cystic Fibrosis Research and Translation Centers are part of an integrated program of research support designed to enhance multidisciplinary research in pathogenesis and treatment of cystic fibrosis.  Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions or a group of institutions with an established, comprehensive research base in cystic fibrosis.  The goal of these CF Research and Translation Centers is to support research to develop and test therapies for CF.  These Centers provide resources for communication and collaboration between basic and clinical researchers to study the multiple organ systems affected by CF.​​​​​​​​​​​​​​​​​​​​​

 

 NIDDK Staff

 
Thomas Eggerman, M.D., Ph.D.Cystic fibrosis research and translation centers, inborn errors of metabolism, clinical trials, and islet transplantation

Funding Mechanisms

NIDDK funds Cystic Fibrosis Centers under the P30 funding mechanism

Center Sites

  • University of North Carolina
  • University of Alabama at Birmingham
  • University of California San Francisco
  • University of Pittsburgh
  • University of Washington
  • University of Pennsylvania
  • University of Iowa   

 

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
1/17/2017Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01) (Summary) PAR-17-123
1/5/2017Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement (Admin Supp) (Summary) PA-17-101
12/23/2016Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) (Summary) PA-17-098
12/12/2016Administrative Supplement for Research on Sex/Gender Influences (Admin Supp) (Summary) PA-17-078
11/25/2016Limited Competition: Research Resource for Human Organs and Tissues (U42) (Summary) RFA-OD-17-001
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.

 

 Research Resources

 
Resource NameDescription
Mouse Metabolic Phenotyping Centers

The MMPC is a National Institutes of Health-sponsored resource that provides experimental testing services to scientists studying diabetes, obesity, diabetic complications, and other metabolic diseases in mice.

Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
NIDDK Information Network

The NIDDK Information Network (dkNET), serves the needs of basic and clinical investigators by providing seamless access to large pools of data relevant to the mission of NIDDK. The goal of dkNET is to develop a community-based network for…

NIDDK Repository for Biosamples and Data

Supports Data, Biosample, and Genetic Repositories to increase the impact of current and previously funded NIDDK studies by making their data and biospecimens available to the broader scientific community. These Repositories enable scientists not…

View Additional Research Resources

 

 NIDDK Active Trials in Cystic Fibrosis

 
​View related clinical trials from ClinicalTrials.gov​.

 

 Related Study Sections

 
​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections​ from the NIH's Center for Scientific Review.